These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. LABA monotherapy in asthma: an avoidable problem. Morales DR Br J Gen Pract; 2013 Dec; 63(617):627-8. PubMed ID: 24351465 [No Abstract] [Full Text] [Related]
10. The article by Daley-Yates et al. Crompton GK Clin Ther; 2010 May; 32(5):996-7; author reply 997-1000. PubMed ID: 20685508 [No Abstract] [Full Text] [Related]
11. Salmeterol and tolerance. Lipworth BJ; Jackson CM Chest; 2000 Feb; 117(2):609-11. PubMed ID: 10669718 [No Abstract] [Full Text] [Related]
12. Salmeterol xinafoate in children. Robertson CF; Mellis C; Staugas R; Isles AF; Landau LI Med J Aust; 1995 Apr; 162(8):443. PubMed ID: 7746185 [No Abstract] [Full Text] [Related]
13. Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life. Edin HM; Andersen LB; Schoaf L; Scott-Wilson CA; Ho SY; Ortega HG Ann Allergy Asthma Immunol; 2009 Apr; 102(4):323-7. PubMed ID: 19441604 [TBL] [Abstract][Full Text] [Related]
14. Inhaled salmeterol/fluticasone propionate: a review of its use in asthma. Reynolds NA; Lyseng-Williamson KA; Wiseman LR Drugs; 2005; 65(12):1715-34. PubMed ID: 16060707 [TBL] [Abstract][Full Text] [Related]
15. Respiratory arrests in young asthmatics on salmeterol. Clark CE; Ferguson AD; Siddorn JA Respir Med; 1993 Apr; 87(3):227-8. PubMed ID: 8497705 [No Abstract] [Full Text] [Related]
16. Comparison of an inhaled corticosteroid (triamcinolone acetonide) to a long-acting bronchodilator (salmeterol), the combination, and placebo in mild-moderate adult asthmatic patients. Creticos PS; Freidhoff LR; Bernstein DI; Chu T; Khattignavong AP; Pasatiempo AM; Lim JC Int Arch Allergy Immunol; 1999; 118(2-4):345-6. PubMed ID: 10224440 [No Abstract] [Full Text] [Related]
17. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. Castle W; Fuller R; Hall J; Palmer J BMJ; 1993 Apr; 306(6884):1034-7. PubMed ID: 8098238 [TBL] [Abstract][Full Text] [Related]
18. Several studies have shown salmeterol to be more potent than salbutamol for systemic effects. Bennett J; Tattersfield AE BMJ; 1997 Jul; 315(7100):121. PubMed ID: 9240063 [No Abstract] [Full Text] [Related]
19. A comparison of the efficacy of long-acting beta 2-agonists: eformoterol via Turbohaler and salmeterol via pressurized metered dose inhaler or Accuhaler, in mild to moderate asthmatics. Force Research Group. Campbell LM; Anderson TJ; Parashchak MR; Burke CM; Watson SA; Turbitt ML Respir Med; 1999 Apr; 93(4):236-44. PubMed ID: 10464887 [TBL] [Abstract][Full Text] [Related]
20. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Markham A; Jarvis B Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]